agilon health (NYSE:AGL) Stock Price Down 7.9% - Here's What Happened

Shares of agilon health, inc. (NYSE:AGL - Get Free Report) were down 7.9% during mid-day trading on Thursday . The company traded as low as $3.25 and last traded at $3.23. Approximately 2,021,142 shares were traded during mid-day trading, a decline of 60% from the average daily volume of 5,055,943 shares. The stock had previously closed at $3.50.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on AGL shares. JMP Securities cut shares of agilon health from an "outperform" rating to a "market perform" rating in a research note on Monday, November 11th. Macquarie initiated coverage on shares of agilon health in a research note on Monday, December 16th. They issued a "neutral" rating and a $3.00 price objective on the stock. TD Cowen reduced their price target on shares of agilon health from $6.00 to $2.00 and set a "hold" rating on the stock in a research report on Monday, November 11th. Sanford C. Bernstein lifted their price target on shares of agilon health from $2.50 to $3.15 and gave the stock a "market perform" rating in a research report on Wednesday, January 15th. Finally, Stifel Nicolaus reduced their price target on shares of agilon health from $7.00 to $2.00 and set a "hold" rating on the stock in a research report on Tuesday, November 12th. Two research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $4.03.

agilon health Trading Down 1.4 %

The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The business's fifty day moving average is $2.58 and its 200 day moving average is $3.26. The firm has a market capitalization of $1.35 billion, a price-to-earnings ratio of -3.49 and a beta of 0.67.

agilon health (NYSE:AGL - Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The business had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. During the same quarter in the previous year, the firm posted ($0.06) earnings per share. Equities analysts predict that agilon health, inc. will post -0.59 earnings per share for the current year.

Insider Buying and Selling at agilon health

In other agilon health news, Director Diana Mckenzie purchased 12,500 shares of the stock in a transaction on Monday, November 25th. The shares were purchased at an average cost of $2.28 per share, for a total transaction of $28,500.00. Following the purchase, the director now owns 51,319 shares of the company's stock, valued at approximately $117,007.32. This represents a 32.20 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director John William Wulf purchased 45,000 shares of the stock in a transaction on Thursday, December 5th. The stock was acquired at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the purchase, the director now directly owns 206,133 shares in the company, valued at approximately $449,369.94. The trade was a 27.93 % increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have acquired 90,000 shares of company stock worth $198,100. Insiders own 3.20% of the company's stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. State Street Corp boosted its holdings in shares of agilon health by 3.0% during the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company's stock worth $29,277,000 after buying an additional 215,733 shares during the period. Geode Capital Management LLC boosted its stake in agilon health by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company's stock valued at $27,097,000 after purchasing an additional 84,889 shares during the period. Charles Schwab Investment Management Inc. boosted its stake in agilon health by 49.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company's stock valued at $8,629,000 after purchasing an additional 1,498,524 shares during the period. Citigroup Inc. boosted its stake in agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company's stock valued at $7,971,000 after purchasing an additional 1,941,993 shares during the period. Finally, JPMorgan Chase & Co. boosted its stake in agilon health by 326.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company's stock valued at $5,563,000 after purchasing an additional 1,083,492 shares during the period.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.